Carregant...

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: Triple negative breast cancer is a disease with limited treatment options and the poorest outcome across all breast cancer subtypes, thus the need for new effective therapies is high. We recently found that navitoclax displays synergistic anti-proliferative and apoptotic activities w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Marczyk, Michal, Patwardhan, Gauri A., Zhao, Jun, Qu, Rihao, Li, Xiaotong, Wali, Vikram B., Gupta, Abhishek K., Pillai, Manoj M., Kluger, Yuval, Yan, Qin, Hatzis, Christos, Pusztai, Lajos, Gunasekharan, Vignesh
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563413/
https://ncbi.nlm.nih.gov/pubmed/32911681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092551
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!